CEU COURSE: INVESTIGATION OF BROADLY REACTIVE ANTIBODIES

In this program, the steps taken in distinguishing the difference between warm autoantibodies, high incidence alloantibodies, multiple alloantibodies and interfering therapeutic agents are discussed. Multiple techniques useful in assisting in antibody identification beyond the initial panel results are presented, including: enzyme treatment, DTT treatment, absorption techniques and phenotype.

TARGET AUDIENCE: Technologists, Technicians, Laboratory Managers

LEVEL: Intermediate

SUCCESSSM CREDITS: 1.0 CEU

Enter Course

LEARNING OBJECTIVES
At the conclusion of this course, participants should be able to:

  1. Define broadly reactive antibody and discuss its clinical importance.
  2. Describe the serologic investigation of warm-reactive antibody, multiple common alloantibodies and an antibody to a high incidence antigen.

LEARNING TASKS
To receive CEU credit for this course, participants must:

  1. Review the presentation "Investigation of Broadly Reactive Antibodies," or read the PowerPoint slides and accompanying notes available as a printable Adobe Reader® file.
  2. Take the online Post-Test.
  3. Complete the online Course Evaluation.
  4. Print the certificate awarding 1.0 SUCCESSSM program CEU.

FACULTY
Kelly Kezeor MT(ASCP)
Hospital Program Coordinator
American Red Cross Biomedical Services, Midwest Region, Omaha NE

LEARNING REFERENCES 

  1. Fung, Mark K., Brenda J. Grossman, Christopher D. Hillyer, and Connie M. Westhoff.

  2. Technical Manual. Bethesda, MD: American Association of Blood Banks, 2014. Print.

  3. Harmening, Denise. Modern Blood Banking and Transfusion Practices. Philadelphia: F.A. Davis, 2005. Print.

  4. Reid, Marion E., Christine Lomas-Francis, and Martin Olsson. The Blood Group

  5. Antigen Factsbook. Oxford: Academic, 2012. Print.

  6. Roback J, Grossman BJ, Harris T, Hillyer CD, eds. Technical Manual. Bethesda, Md: AABB; 2011.

DISCLAIMER
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the American Red Cross Biomedical Services. Information herein is presented for educational purposes and not to endorse off-label use. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

RELEASE DATE: 04/22/2019

EXPIRATION DATE: 04/21/2021

ESTIMATED TIME TO COMPLETE ACTIVITY:
1 hour

Last modified: Monday, April 22, 2019, 08:45 PM